LUKE P LEMKE

Allopathic & Osteopathic Physicians|Family Medicine COLUMBUS, NE NPI 1104820489

General Payments — all program years on this page

$2,371.07

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 170
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $236.31 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $236.3115

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $599.8359
2019 $536.6541
2020 $187.4813
2021 $307.6417
2022 $196.6412
2023 $306.5213
2024 $236.3115

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096598771 Novo Nordisk Inc $16.38 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096609524 Novo Nordisk Inc $15.55 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096967030 Novo Nordisk Inc $14.37 07/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104635107 AstraZeneca Pharmaceuticals LP $13.89 07/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105809341 AstraZeneca Pharmaceuticals LP $15.03 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116635490 GlaxoSmithKline, LLC. $13.62 11/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117874509 Boehringer Ingelheim Pharmaceuticals, Inc. $14.50 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120648206 Baxter Healthcare $14.56 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1129443818 Esperion Therapeutics, Inc. $15.64 08/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135136496 Lilly USA, LLC $13.11 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135140816 Lilly USA, LLC $23.48 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135160960 Lilly USA, LLC $14.98 06/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135161475 Lilly USA, LLC $19.60 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141885385 Merck Sharp & Dohme LLC $13.65 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144603444 Xeris Pharmaceuticals, Inc. $17.95 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.